Patents by Inventor Matthias LAUDES

Matthias LAUDES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Publication number: 20230235020
    Abstract: The invention provides a polypeptide dimer comprising two gp130-Fc fusion peptides for use in the treatment of ASCVD in human patients, preferably of high-risk ASCVD in human patients, more preferably of very-high-risk ASCVD in human patients.
    Type: Application
    Filed: June 9, 2021
    Publication date: July 27, 2023
    Inventors: Dominik Schulte, Georg Wätzig, Matthias Laudes, Stefan Schreiber
  • SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS FOR TOPICAL INTESTINAL DELIVERY OF VITAMIN B3
    Publication number: 20210275513
    Abstract: The present invention relates to microcapsules comprising a core containing vitamin B3, which are characterised by a coating layer system comprising two layers of shellac and a pH-modulating substance provided between the two layers of shellac.
    Type: Application
    Filed: April 12, 2017
    Publication date: September 9, 2021
    Applicants: CONARIS RESEARCH INSTITUTE AG, CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL
    Inventors: Karin SCHWARZ, Julia KEPPLER, Eva-Maria THEISMANN, Jörg KNIPP, Daniela FANGMANN, Matthias LAUDES, Stefan SCHREIBER, Georg WÄTZIG